Time to Treat Hypertension in Patients with Aortic Stenosis
Historically, patients with aortic stenosis (AS) rarely had concurrent systemic hypertension (HTN). Now, echocardiography allows early diagnosis, calcific remodeling has replaced rheumatic heart disease as the most prevalence cause of AS in the developed world, and the population of adults with AS is older, paralleling the demographic shift in the age of our population.1,2 In combination, these trends mean that HTN is a more common co-morbidity in patients with AS and is coexistent for a longer period of time prior to aortic valve replacement (AVR). In studies involving younger patients with AS, the prevalence of HTN is 30-40%,3 whereas in recent series involving older patients at high risk for AVR, the prevalence of HTN is 75% or higher.4,5
- Received August 13, 2013.
- Accepted August 16, 2013.